Volloch V, Rits-Volloch S
Genes (Basel). 2025; 16(1.
PMID: 39858593
PMC: 11764795.
DOI: 10.3390/genes16010046.
Jeong Y, Li W, Yang H, Kim S, Choi H, Choi J
Antioxidants (Basel). 2024; 13(11).
PMID: 39594488
PMC: 11591166.
DOI: 10.3390/antiox13111346.
Volloch V, Rits-Volloch S
Int J Mol Sci. 2024; 25(18).
PMID: 39337400
PMC: 11432332.
DOI: 10.3390/ijms25189913.
Granov R, Vedad S, Wang S, Durham A, Shah D, Pasinetti G
Mol Neurobiol. 2024; 62(1):1205-1224.
PMID: 38967905
PMC: 11711138.
DOI: 10.1007/s12035-024-04339-6.
Volloch V, Rits-Volloch S
Int J Mol Sci. 2024; 25(11).
PMID: 38892224
PMC: 11172602.
DOI: 10.3390/ijms25116036.
On the Inadequacy of the Current Transgenic Animal Models of Alzheimer's Disease: The Path Forward.
Volloch V, Rits-Volloch S
Int J Mol Sci. 2024; 25(5).
PMID: 38474228
PMC: 10932000.
DOI: 10.3390/ijms25052981.
Next Generation Therapeutic Strategy for Treatment and Prevention of Alzheimer's Disease and Aging-Associated Cognitive Decline: Transient, Once-in-a-Lifetime-Only Depletion of Intraneuronal Aβ (Aβ) by Its Targeted Degradation via Augmentation of....
Volloch V, Rits-Volloch S
Int J Mol Sci. 2023; 24(24).
PMID: 38139415
PMC: 10744314.
DOI: 10.3390/ijms242417586.
Effects of Redox Homeostasis and Mitochondrial Damage on Alzheimer's Disease.
Wu Y, Hsieh H
Antioxidants (Basel). 2023; 12(10).
PMID: 37891895
PMC: 10604635.
DOI: 10.3390/antiox12101816.
Principles of Design of Clinical Trials for Prevention and Treatment of Alzheimer's Disease and Aging-Associated Cognitive Decline in the ACH2.0 Perspective: Potential Outcomes, Challenges, and Solutions.
Volloch V, Rits-Volloch S
J Alzheimers Dis Rep. 2023; 7(1):921-955.
PMID: 37849639
PMC: 10578334.
DOI: 10.3233/ADR-230037.
Mitochondrial dynamics in health and disease: mechanisms and potential targets.
Chen W, Zhao H, Li Y
Signal Transduct Target Ther. 2023; 8(1):333.
PMID: 37669960
PMC: 10480456.
DOI: 10.1038/s41392-023-01547-9.
The Amyloid Cascade Hypothesis 2.0 for Alzheimer's Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy.
Volloch V, Rits-Volloch S
Int J Mol Sci. 2023; 24(15).
PMID: 37569624
PMC: 10419172.
DOI: 10.3390/ijms241512246.
Overcoming the Limitations of CRISPR-Cas9 Systems in : Off-Target Effects, Epigenome, and Mitochondrial Editing.
Sato G, Kuroda K
Microorganisms. 2023; 11(4).
PMID: 37110464
PMC: 10145089.
DOI: 10.3390/microorganisms11041040.
Multiple Sclerosis: Inflammatory and Neuroglial Aspects.
Papiri G, DAndreamatteo G, Cacchio G, Alia S, Silvestrini M, Paci C
Curr Issues Mol Biol. 2023; 45(2):1443-1470.
PMID: 36826039
PMC: 9954863.
DOI: 10.3390/cimb45020094.
The Amyloid Cascade Hypothesis 2.0: Generalization of the Concept.
Volloch V, Rits-Volloch S
J Alzheimers Dis Rep. 2023; 7(1):21-35.
PMID: 36777328
PMC: 9912825.
DOI: 10.3233/ADR-220079.
The role of Aβ in Alzheimer's Disease as an Evolutionary Outcome of Optimized Innate Immune Defense.
Tatar M
J Prev Alzheimers Dis. 2022; 9(4):580-588.
PMID: 36281662
PMC: 10535726.
DOI: 10.14283/jpad.2022.68.
The Amyloid Cascade Hypothesis 2.0: On the Possibility of Once-in-a-Lifetime-Only Treatment for Prevention of Alzheimer's Disease and for Its Potential Cure at Symptomatic Stages.
Volloch V, Rits-Volloch S
J Alzheimers Dis Rep. 2022; 6(1):369-399.
PMID: 36072366
PMC: 9397896.
DOI: 10.3233/ADR-220031.
Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope.
Nabi S, Khan A, Siddiqui E, Rehman M, Alshahrani S, Arafah A
Oxid Med Cell Longev. 2022; 2022:4759963.
PMID: 35607703
PMC: 9124149.
DOI: 10.1155/2022/4759963.
News from Mars: Two-Tier Paradox, Intracellular PCR, Chimeric Junction Shift, Dark Matter mRNA and Other Remarkable Features of Mammalian RNA-Dependent mRNA Amplification. Implications for Alzheimer's Disease, RNA-Based Vaccines and mRNA Therapeutics.
Volloch V, Rits-Volloch S
Ann Integr Mol Med. 2021; 2:131-173.
PMID: 33942036
PMC: 8088752.
DOI: 10.33597/aimm.02-1009.
Neuroprotective Activity of Polyphenol-Rich Pall against Oxidative Stress in Glutamate-Stimulated HT-22 Cells and a Scopolamine-Induced Amnesia Animal Model.
Kim H, Baek S, Sok D, Lee K, Kim Y, Kim M
Antioxidants (Basel). 2020; 9(9).
PMID: 32967207
PMC: 7555254.
DOI: 10.3390/antiox9090895.
Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
Volloch V, Olsen B, Rits S
Ann Integr Mol Med. 2020; 2(1):90-114.
PMID: 32617536
PMC: 7331974.
DOI: 10.33597/aimm.02-1007.